Cargando…

Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge

West Nile virus (WNV) is a mosquito-borne flavivirus that is endemic in Africa, the Middle East, Europe and the United States. There is currently no antiviral treatment or human vaccine available to treat or prevent WNV infection. DNA plasmid-based vaccines represent a new approach for controlling i...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Filette, Marina, Soehle, Silke, Ulbert, Sebastian, Richner, Justin, Diamond, Michael S., Sinigaglia, Alessandro, Barzon, Luisa, Roels, Stefan, Lisziewicz, Julianna, Lorincz, Orsolya, Sanders, Niek N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913677/ https://www.ncbi.nlm.nih.gov/pubmed/24503579 http://dx.doi.org/10.1371/journal.pone.0087837

Ejemplares similares

T Cell Epitope Mapping of the E-Protein of West Nile Virus in BALB/c Mice
por: De Filette, Marina, et al.
Publicado: (2014)

Vaccine-Induced Protection of Rhesus Macaques against Plasma Viremia after Intradermal Infection with a European Lineage 1 Strain of West Nile Virus
por: Verstrepen, Babs E., et al.
Publicado: (2014)

Recent progress in West Nile virus diagnosis and vaccination
por: De Filette, Marina, et al.
Publicado: (2012)

Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop
por: Chabierski, Stefan, et al.
Publicado: (2014)

Correction: Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge
Publicado: (2014)

Antibody Responses in Humans Infected with Newly Emerging Strains of West Nile Virus in Europe
por: Chabierski, Stefan, et al.
Publicado: (2013)

Experimental Infection of Rhesus Macaques and Common Marmosets with a European Strain of West Nile Virus
por: Verstrepen, Babs E., et al.
Publicado: (2014)

Modelling West Nile Virus and Usutu Virus Pathogenicity in Human Neural Stem Cells
por: Riccetti, Silvia, et al.
Publicado: (2020)

West Nile virus infection in individuals with pre-existing Usutu virus immunity, northern Italy, 2018
por: Sinigaglia, Alessandro, et al.
Publicado: (2019)

Type I IFN stimulates lymph node stromal cells from adult and old mice during a West Nile virus infection
por: Bennett, Allison K., et al.
Publicado: (2023)

Infection with Non-Lethal West Nile Virus Eg101 Strain Induces Immunity that Protects Mice against the Lethal West Nile Virus NY99 Strain
por: Kumar, Mukesh, et al.
Publicado: (2014)

Protection of mice deficient in mature B cells from West Nile virus infection by passive and active immunization
por: Giordano, Daniela, et al.
Publicado: (2017)

Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection
por: Wessel, Alex W., et al.
Publicado: (2021)

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice
por: Spohn, Gunther, et al.
Publicado: (2010)

Human West Nile Virus Lineage 2 Infection: Epidemiological, Clinical, and Virological Findings
por: Pacenti, Monia, et al.
Publicado: (2020)

Priming With Rhinovirus Protects Mice Against a Lethal Pulmonary Coronavirus Infection
por: Cox, Garrison, et al.
Publicado: (2022)

Decreased antiviral immune response within the central nervous system of aged mice is associated with increased lethality of West Nile virus encephalitis
por: Funk, Kristen E., et al.
Publicado: (2021)

West Nile virus vaccines – current situation and future directions
por: Ulbert, Sebastian
Publicado: (2019)

AgBR1 antibodies delay lethal Aedes aegypti-borne West Nile virus infection in mice
por: Uraki, Ryuta, et al.
Publicado: (2019)

Orf virus DNA prime-protein boost strategy is superior to adenovirus-based vaccination in mice and sheep
por: Wang, Yan, et al.
Publicado: (2023)

Recombinant Envelope-Proteins with Mutations in the Conserved Fusion Loop Allow Specific Serological Diagnosis of Dengue-Infections
por: Rockstroh, Alexandra, et al.
Publicado: (2015)

Protective immune responses against West Nile virus are primed by distinct complement activation pathways
por: Mehlhop, Erin, et al.
Publicado: (2006)

Altered Protein Networks and Cellular Pathways in Severe West Nile Disease in Mice
por: Fraisier, Christophe, et al.
Publicado: (2013)

Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus
por: Martina, Byron E., et al.
Publicado: (2008)

Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop
por: Rockstroh, Alexandra, et al.
Publicado: (2017)

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
por: Tan, Hyon-Xhi, et al.
Publicado: (2021)

Correction: Altered Protein Networks and Cellular Pathways in Severe West Nile Disease in Mice
por: Fraisier, Christophe, et al.
Publicado: (2013)

Disruption of G-Protein γ(5) Subtype Causes Embryonic Lethality in Mice
por: Moon, Anne M., et al.
Publicado: (2014)

Prion protein protects mice from lethal infection with influenza A viruses
por: Chida, Junji, et al.
Publicado: (2018)

Optimisation of Prime–Boost Immunization in Mice Using Novel Protein-Based and Recombinant Vaccinia (Tiantan)-Based HBV Vaccine
por: Chen, Hong, et al.
Publicado: (2012)

Heterologous prime-boost vaccination based on Polymorphic protein D protects against intravaginal Chlamydia trachomatis infection in mice
por: Russi, Romina Cecilia, et al.
Publicado: (2022)

Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice
por: Chiuppesi, Flavia, et al.
Publicado: (2017)

Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infection
por: Weiß, Rebecca, et al.
Publicado: (2023)

Heterologous Prime-Boost Immunization with DNA Vaccine and Modified Recombinant Proteins Enhances Immune Response against Trueperella pyogenes in Mice
por: Huang, Ting, et al.
Publicado: (2022)

Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in Mice
por: Stephan, Ann-Sophie, et al.
Publicado: (2023)

Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the Cd34-Related Protein Podocalyxin
por: Doyonnas, Regis, et al.
Publicado: (2001)

Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice
por: Yamamoto, Kenta, et al.
Publicado: (2012)

A potently neutralizing human monoclonal antibody targeting an epitope in the West Nile virus E protein preferentially recognizes mature virions
por: Goo, Leslie, et al.
Publicado: (2018)

Deletion of Pregnancy Zone Protein and Murinoglobulin-1 Restricts the Pathogenesis of West Nile Virus Infection in Mice
por: Krause, Keeton, et al.
Publicado: (2019)

Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime–protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology
por: Carine, Letellier, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_irge9459a0ebsn64netq813afm